ipratropium and levosalbutamol

ipratropium; levosalbutamol · Neutec Ar-Ge San ve Tic A.Ş

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ipratropium and levosalbutamol, covering 2023-10-03 to 2023-10-03. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 3]

See pricing